BackTable Urology
BackTable Inc.Audio
- Format:
- Podcast
- New episodes:
- Several times a week
- Typical length:
- about 50 minutes
- Latest episode:
About this show
The BackTable Urology Podcast is a resource for practicing urologists to learn tips, techniques, and practical advice from their peers in the field. Listen here or on the streaming platform of your choice.
Covers: urology, medicine, prostate cancer, bladder cancer, healthcare policy, medical careers, clinical AI, kidney stones, neurogenic bladder, continuing medical education
Show details and episodes come from the publisher's public feed at feeds.megaphone.fm. Last updated . Names, artwork and text belong to their publishers.
Recently on this show
Summary of recent episodes, drawn from the publisher's feed.
This podcast gives practicing urologists practical tips and techniques from colleagues in the field. Recent episodes cover RVU changes, direct contracting in healthcare, mid-career challenges, overactive bladder in men, intermediate-risk bladder cancer, and AI in urology care.
Cosmos
Similar in subject
- The Uromigos
Both cover: bladder cancer, prostate cancer - You Are Not Broken
Both cover: urology
Similar shows
Explore more
Episodes
Ep. 304 Optimizing Office Protocols for Urological Incontinence Procedures with Dr. Michael Kennelly and Dr. Jason Kim
· 41 min
How do you keep no-shows low and patient satisfaction high in an office-based overactive bladder (OAB) practice? In this episode of BackTable Urology, Dr. Michael Kennelly and Dr. Jason Kim join guest host Dr. Polina Reyblat to share practical strategies for improving efficiency, reducing cancellations, and optimizing the patient experience for OAB and urinary incontinence procedures. --- Get the BackTable app https://www.backtable.com/app --- This podcast was developed in collaboration with Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) https://sufuorg.com/home.aspx --- Timestamps 00:00 - Introduction 02:08 - Pre Visit Optimization 05:49 - Botox Protocol 11:31 - Spa-Style Comfort 14:46 - Prior Auth and Medicare LCD 21:25 - PTNS Workflow Challenges 24:52 - Stacking Procedures 27:55 - Bulking Agent Clinic Workflow 36:17 - Rapid Fire Tips --- More about this episode The panel discusses streamlined Botox workflows, patient-centered approaches to anxiety and pain management, percutaneous tibial nerve stimulation (PTNS) and peripheral nerve evaluation (PNE) scheduling, office-based bulking procedures, and the evolving Medicare LCD documentation requirements. They also share tips for procedure-day planning, staffing, prior authorizations, and reducing no-shows while maintaining high-quality care. --- Resources Relaxing Environment Lowers Anxiety During Chemodenervation: a Randomized Trial https://journals.lww.com/fpmrs/abstract/2026/04000/relaxing_environment_lowers_anxiety_during.6.aspx --- BackTable Urology is the go-to podcast for urologists, urologic oncologists, and urogynecologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app
Not rated yetEp. 303 PARP Inhibitors: Clinical Trials & Real-World Applications with Dr. Neeraj Agarwal and Dr. Arun Azad
· 1 hr 15 min
Keeping patients on PARP inhibitors long enough to see real benefit often comes down to proactive side effect management. In this episode of BackTable Urology, Dr. Neeraj Agarwal and Dr. Arun Azad join host Dr. Alan Tan to discuss practical, evidence-based strategies for managing hematologic and GI toxicities in advanced prostate cancer patients receiving PARP inhibitors. --- Get the BackTable app https://www.backtable.com/app --- This podcast is supported by an educational grant from Pfizer. --- Timestamps 00:00 - Introduction 06:17 - Managing Anemia 11:12 - Side Effect Profiles 19:33 - Transfusions vs ESAs 26:43 - Docetaxel vs PARP Inhibitors 30:27 - Side Effect Management Pearls 40:18 - Team Based Monitoring 52:27 - Tissue Versus Liquid 01:01:24 - Genetic Counseling Workflow 01:07:07 - Trial Equity and Access --- More about this episode The doctors discuss the importance of close anemia monitoring during the critical first 3 to 4 months of therapy, maintaining dose intensity, proactive antiemetic use, and the role of exercise and resistance training in combating fatigue. The conversation also covers differences in toxicity profiles between PARP agents, the value of multidisciplinary care teams, molecular advances in molecular and germline testing, and the evolving landscape of emerging therapies in prostate care. --- Resources Talazoparib plus enzalutamide in men with metastatic castration-resistant prostate cancer: final overall survival results from the randomised, placebo-controlled, phase 3 TALAPRO-2 trial https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00684-1/abstract BRCAAway: A randomized phase 2 trial of abiraterone, olaparib, or abiraterone + olaparib in patients with metastatic castration-resistant prostate cancer (mCRPC) bearing homologous recombination-repair mutations (HRRm). https://ascopubs.org/doi/10.1200/JCO.2024.42.4_suppl.19 --- BackTable Urology is the go-to podcast for urologists, urologic oncologists, and urogynecologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app
Not rated yetEp. 302 Male Infertility: Diagnosis & Guidelines Update with Dr. Robert E. Brannigan
· 46 min
Male factor infertility accounts for nearly half of all infertility cases, yet male evaluation is often delayed or overlooked. In this episode of BackTable Urology, Dr. Robert Brannigan joins guest host Dr. Catherine Nam to unpack the 2024 AUA/ASRM Male Infertility Guideline update and discuss how the field is evolving beyond basic semen analysis. --- Get the BackTable app https://www.backtable.com/app --- Timestamps 00:00 - Introduction 04:12 - Rationale Behind the Updates 09:37 - Concurrent Couple Evaluation 15:01 - Diagnosis, Assessment and Evaluation 20:33 - Y Chromosome Microdeletion Testing 23:54 - Workup for Recurrent Pregnancy Loss 33:57 - Pelvic MRI for EDO 36:46 - MicroTESE 40:15 - Future Research Directions 44:09 - Closing Takeaways --- More about this episode They review updated definitions of infertility, challenges with WHO semen reference ranges, and the need for comprehensive male assessment. The discussion also covers sperm DNA fragmentation, recurrent pregnancy loss, the role of pelvic MRI for ejaculatory duct obstruction, micro-TESE for nonobstructive azoospermia, and the latest directions in male infertility research. --- Resources Increased risk of incident chronic medical conditions in infertile men: analysis of United States claims data: https://pubmed.ncbi.nlm.nih.gov/26674559/ Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline https://www.auanet.org/guidelines-and-quality/guidelines/male-infertility Sixth edition of the World Health Organization laboratory manual of semen analysis: Updates and essential take away for busy clinicians https://pmc.ncbi.nlm.nih.gov/articles/PMC10929669/ --- BackTable Urology is the go-to podcast for urologists, urologic oncologists, and urogynecologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app
Not rated yetEp. 301 Integrating Biomarkers in Prostate Cancer Treatment with Dr. Udit Singhal
· 34 min
Are biomarkers the missing link in personalized prostate cancer care? What is the practical role of biomarkers across the prostate cancer treatment continuum? In this episode of BackTable Urology, Dr. Udit Singhal (University of Michigan) joins Dr. Ruchika Talwar (Vanderbilt University) to explore the evolving role of genomic classifiers and biomarkers in prostate cancer care. --- Get the BackTable app https://www.backtable.com/app --- This podcast is supported by Veracyte https://www.veracyte.com/decipher-prostate --- Timestamps 00:00 - Introduction 04:58 - Current State 10:07 - Interpreting High Risk Scores 13:25 - Intermediate Risk Decisions 16:18 - Imaging vs. Genomics 18:26 - Advanced Disease Evidence 22:02 - AI and Clinical Trials 29:52 - Conclusions --- More about this episode They review commonly used assays, including Prolaris, Oncotype Dx, Decipher, and ConfirmMDx and emphasize how these tools complement traditional clinical and pathologic risk factors. The discussion highlights practical applications across the disease continuum from initial diagnosis and active surveillance to intermediate-risk management and post-prostatectomy salvage decisions. They also explore emerging AI-driven tools and ongoing trials, highlighting the importance of contextualizing biomarker data within the broader clinical picture and using it to inform, rather than dictate, patient-centered care. --- BackTable Urology is the go-to podcast for urologists, urologic oncologists, and urogynecologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app
Not rated yetEp. 300 Renal Cell Carcinoma and Venous Thrombus: A Deep Dive with Dr. Vidit Sharma
· 1 hr 43 min
When Renal Cell Carcinoma (RCC) invades the veins, the stakes and the surgical challenges rise. Are you prepared? In this episode, Dr. Vidit Sharma (Mayo Clinic) joins guest host Dr. Daniel Roberson to review Renal Cell Carcinoma (RCC) with Venous Tumor Thrombus (VTT), seen in 4 to 10% of cases. They review Mayo level classification and how CT and MRI venography guide surgical planning by defining thrombus extent and IVC involvement. --- Get the BackTable app https://www.backtable.com/app --- Timestamps 00:00 - Introduction 03:03 - What is a Venous Tumor Thrombus? 12:32 - Presentation and Workup 31:49 - Preoperative Considerations 40:26 - Building the Dream Team 46:06 - Preop Counseling and Risks 51:24 - The Operation 01:31:01 - Outcomes and Adjuvant Immunotherapy 01:36:40 - Future Neoadjuvant Shrinkage 01:39:40 - Final Takeaways --- More about this episode They also cover key management decisions, including when anticoagulation is appropriate and why embolic urgency is often overestimated. Dr. Sharma highlights the importance of experienced multidisciplinary teams, reviews surgical considerations across thrombus levels, and discusses outcomes, including risk stratification with the TeNNiS model and evolving roles for systemic therapy. --- Resources Outcomes for patients with renal tumors and venous tumor thrombus https://www.mayoclinic.org/medical-professionals/urology/news/outcomes-for-patients-with-renal-tumors-and-venous-tumor-thrombus/mac-20570379 TeNNiS Score https://www.goldjournal.net/article/S0090-4295(26)00078-6/fulltext --- BackTable Urology is the go-to podcast for urologists, urologic oncologists, and urogynecologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app
Not rated yetEp. 299 Clinical Decision-Making in Urodynamics: From Stress Incontinence to Neurogenic Bladders with Dr. Howard Goldman and Dr. David Ginsberg
· 52 min
When does urodynamics actually change management and when is it unnecessary? In BackTable Urology’s latest collaboration with the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU), Dr. Howard Goldman and Dr. David Ginsberg join Dr. Giulia Ippolito to discuss the evidence-based use of urodynamics across a range of clinical scenarios. --- Get the BackTable app https://www.backtable.com/app --- Timestamps 00:00 - Introduction 05:04 - Case: Male Urinary Retention 12:38 - Case: Failed Sling 18:44 - Case: Parkinson’s OAB 21:50 - Case: Post-Prostatectomy 26:48 - Prolapse Without Urodynamics 32:29 - Obstruction Workup 36:16 - Refractory OAB 42:49 - Interstitial Cystitis 45:18 - Recurrent UTI Evaluation 50:16 - Conclusions --- More about this episode They review guideline-driven indications and limitations of urodynamic testing, emphasizing that many common conditions do not routinely require testing. Through case-based discussion, they highlight situations where urodynamics can meaningfully inform care, such as complex neurogenic patients and cases requiring differentiation between obstruction and detrusor underactivity. The conversation highlights the importance of clinical judgment, targeted use of adjuncts such as uroflow, and aligning testing with decision-making to optimize patient outcomes. This podcast is supported by the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU). --- Resources Female Urgency, Trial of Urodynamics as Routine Evaluation (FUTURE study) https://pubmed.ncbi.nlm.nih.gov/34702331/ --- BackTable Urology is the go-to podcast for urologists, urologic oncologists, and urogynecologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app
Not rated yetEp. 298 Saying Yes (and No): Strategic Career Decisions with Dr. Anne Cameron
· 47 min
Is your “yes” advancing your career or just adding to your workload? In collaboration with the Society of Women in Urology (SWIU), this episode of BackTable Urology features timely professional advice from Dr. Anne Cameron (University of Michigan, former SWIU president) and Dr. Helen Bernie (Indiana University) on how to approach yes and no decisions with intention across different stages of your medical career. --- Get the BackTable app https://www.backtable.com/app --- Timestamps 00:00 - Introduction 02:43 - How Yes Changes Over Time 11:34 - Power Dynamics For Trainees 16:11 - Housekeeping Work 18:46 - Kind Versus Nice 22:52 - Delegating And Mentoring 28:07 - Decision-Making Framework 36:21 - FOMO Versus Opportunity 40:30 - Mentorship 45:02 - Final Takeaways --- More about this episode Early in training, saying yes is often driven by power dynamics, while later in a career, it’s competing priorities that make those decisions harder. According to Dr. Cameron, a clear, timely “no” is not only acceptable but often more professional than a delayed response, and leaders play a key role in reinforcing this by giving trainees the space to decline opportunities. This episode also highlights the disproportionate share of “housekeeping” work taken on by women and junior faculty, adding another layer to these decisions. To navigate these challenges, Dr. Cameron offers a practical framework that considers time, role expectations, energy, personal fulfillment, CV value, and long-term goals, while emphasizing the role of mentors and trusted colleagues in providing perspective. --- Resources Society of Women in Urology (SWIU) https://swiu.org/home.aspx --- BackTable Urology is the go-to podcast for urologists, urologic oncologists, and urogynecologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app
Not rated yetEp. 297 How Prostate Artery Embolization Optimizes Radiation Outcomes with Dr. Nainesh Parikh and Dr. Kosj Yamoah
· 46 min
What role does prostate artery embolization (PAE) play in modern prostate cancer care? In this episode of BackTable Urology, Dr. Nainesh Parikh (Interventional Radiology at Moffitt Cancer Center) and Dr. Kosj Yamoah (Radiation Oncology at Moffitt Cancer Center) join Dr. Ruchika Talwar (Vanderbilt University) to discuss how PAE could become a key adjunct in optimizing radiation therapy outcomes. --- Get the BackTable app https://www.backtable.com/app --- Timestamps 00:00 - Introduction 01:44 - Why Use PAE in Cancer 04:08 - Neoadjuvant and Salvage Use 07:26 - Radiation Planning Benefits 12:51 - PAE vs. Surgery 18:36 - SBRT Access 20:48 - Current Evidence and Trials 25:29 - Patient Selection 32:18 - PAE After Radiation 36:56 - When to Avoid PAE 40:29 - Long-Term Implications 44:28 - Conclusions --- More about this episode They review how PAE can improve lower urinary tract symptoms and reduce prostate volume, potentially optimizing patients for radiation therapy, including stereotactic body radiotherapy (SBRT) and brachytherapy. The discussion highlights early clinical data and patient selection considerations such as gland size and symptom burden. Finally, they examine post-radiation applications, technical challenges, and current limitations, emphasizing the need for larger, multicenter trials to better define PAE’s role in prostate cancer treatment pathways. --- Resources Prostate Artery Embolization in the Setting of Prostate Cancer: Review and Opinion https://pmc.ncbi.nlm.nih.gov/articles/PMC11775958/
Not rated yetEp. 296 Overactive Bladder Management: Updates and Guidelines with Dr. Jason Kim
· 44 min
What if we’re waiting too long to offer our OAB patients the treatments that actually work? In this episode of BackTable Urology, Dr. Jason Kim joins host Dr. Anjali Kapur to discuss updates in overactive bladder management and evolving guidelines, including a shift away from rigid stepwise care toward shared decision-making. --- Get the BackTable app https://www.backtable.com/app --- Timestamps 00:00 - Introduction 03:06 - 2024 AUA/SUFU Idiopathic OAB Guideline 07:32 - Patient Experience with OAB 11:59 - Beta-3 Agonists vs Anticholinergics 15:15 - Botox Counseling and Dosing 18:11 - Tibial Nerve Stimulation 25:47 - Sacral Neuromodulation 32:09 - Cost Burden of OAB 39:38 - Evolution of OAB Care 41:39 - Future Research Directions --- More about this episode The conversation positions OAB as a clinical diagnosis, supported by focused initial evaluation and selective use of advanced testing, with attention to the emerging role of ambulatory urodynamics. Dr. Kim and Dr. Kapur review management across the care continuum, including behavioral strategies, pelvic floor physical therapy, and pharmacologic options, with consideration of beta-3 agonists in older patients. The discussion also focuses on earlier use of minimally invasive therapies such as intradetrusor Botox and neuromodulation, and how introducing these options sooner may improve follow-up, reduce delays, and help patients achieve symptom control more efficiently. --- Resources The AUA/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive Bladder (2024) https://www.auanet.org/guidelines-and-quality/guidelines/idiopathic-overactive-bladder Anticholinergic Drug Exposure and the Risk of Dementia https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2736353 Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial https://pubmed.ncbi.nlm.nih.gov/20171677/ Trends in Utilization of Sacral Neuromodulation for Overactive Bladder: Insight From the AUA AQUA Registry https://www.auajournals.org/doi/10.1097/UPJ.0000000000000916 A retrospective longitudinal evaluation of new overactive bladder patients in an FPMRS urologist practice: Are patients following up and utilizing third-line therapies? https://pubmed.ncbi.nlm.nih.gov/33197059/
Not rated yetEp. 295 How to Manage Genitourinary Injuries: ACS Best Practices Explained with Dr. Niels Johnsen
· 47 min
What are the key decision points in managing renal, bladder, and urethral trauma? In this episode of BackTable Urology, Dr. Niels Johnson (Vanderbilt University Medical Center) joins host Dr. George Koch (Ohio State University) to discuss the 2025 American College of Surgeons (ACS) best practice guidelines for genitourinary trauma. --- Get the BackTable app https://www.backtable.com/app --- Timestamps 00:00 - Introduction 05:09 - Who Manages GU Trauma? 13:53 - Purpose of ACS Guidelines 16:13 - Development of ACS Guidelines 20:01 - Foley Catheter Debate 23:26 - Renal Trauma 26:40 - Imaging Protocols and Delays 29:30 - Bladder Trauma and Special Populations 33:15 - Urethral Injuries 38:02 - Genital Wounds and Antibiotics 39:42 - Transfer Criteria and Resources 41:26 - Conclusions --- More about this episode Dr. Johnson and Dr. Koch review the rationale for developing multidisciplinary guidelines and the variability in genitourinary trauma care across institutions. The discussion highlights key management principles, including non-operative strategies for renal trauma, decision-making in bladder and urethral injuries, and how urinary diversion impacts orthopedic and trauma surgical planning. The episode also addresses considerations for special populations, long-term functional outcomes, and practical implementation tools, such as the ACS gap analysis checklist, designed to improve coordination and quality of care across trauma systems. --- Resources ACS Best Practices Guidelines: Management of Genitourinary Injuries (August 2025) https://www.facs.org/media/ya5hcu0s/genitourinary_guidelines.pdf
Not rated yet